A significant increase in the total number of CD45+ cells per mg tumor mass (Figure 5C) as well as percent of CD45+ cells (Figure S5E) was observed in AAC-E7 treated animals (49.3% ± 9.1%) compared to PBS-treated mice (17.0% ± 4.1%). The gene discussed is PTPRC; the disease is neoplasm.